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Abstract
In Pseudomonas aeruginosa many of the clinically relevant resistance mechanisms
result from changes in gene expression as exemplified by the Mex drug efflux
pumps, the AmpC b-lactamase and the carbapenem-specific porin OprD. We used
quantitative real-time-PCR to analyze the expression of these genes in susceptible
and antibiotic-resistant laboratory and clinical strains. In nalB mutants, which
overexpress OprM, we observed a four- to eightfold increase in the expression of
mexA, mexB, and oprM genes. MexX and mexY genes were induced eight to 12
times in the presence of 2mg L1 tetracycline. ThemexC/oprJ andmexE/oprN gene
expression levels were increased 30- to 250-fold and 100- to 760-fold in nfxB and
nfxC mutants, respectively. We further found that in defined laboratory strains
expression levels of ampC and oprD genes paralleled b-lactamase activity and
OprD protein levels, respectively. Our data support the use of quantitative real-
time-PCR chain reaction for the analysis of the antimicrobial resistance gene
expression in P. aeruginosa.
Introduction
Pseudomonas aeruginosa owes its intrinsic and acquired
resistance to antimicrobial agents, biocides, organic solvents
and heavy metals mostly to the expression of chromoso-
mally encoded efflux pumps belonging to the so-called
resistance-nodulation-cell division (RND) family of multi-
drug transporters (for a recent review, see Poole, 2004). For
instance, the constitutively expressed MexAB–OprM (Poole
et al., 1993; Li et al., 1995) and the substrate-inducible
MexXY–OprM (Mine et al., 1999; Ramos-Aires et al., 1999)
efflux systems contribute to the intrinsic resistance of P.
aeruginosa to a large number of structurally unrelated
antimicrobial agents. Mutational events occurring in cog-
nate regulator genes result in the overexpression of these and
other efflux pumps like MexCD–OprJ (Poole et al., 1996a)
and MexEF–OprN (Ko¨hler et al., 1997a). Moreover, the
chromosomally encoded AmpC b-lactamase (Lodge et al.,
1990) and the APH(30)-II aminoglycoside phosphotransfer-
ase (Okii et al., 1983) confer resistance to b-lactams (peni-
cillins, cephalosporins) and to the aminoglycosides
kanamycin and neomycin, respectively. Pseudomonas aeru-
ginosa may also limit the access of hydrophilic molecules by
reducing expression of specific porin channels, like OprD,
leading to carbapenem resistance (Trias et al., 1989). It
therefore appears that many important resistance mechan-
isms in P. aeruginosa result from changes in gene expression.
Therefore, the comparison between resistance gene expres-
sion profiles between susceptible and antibiotic-resistant
isolates should provide information on the underlying
resistance mechanisms.
Western blot analysis has been used in the past to measure
the expression level of efflux pump proteins and the OprD
porin. However, this approach is time consuming and
usually has a low sensitivity. The same arguments apply to
the determination of AmpC expression levels by biochem-
ical methods. We have therefore investigated the possibility
of using quantitative real-time-PCR (qRT-PCR) to study the
expression of antibiotic resistance genes in P. aeruginosa.
This method has the advantage of being fast and sensitive
and could be used in the clinical laboratory.
Materials andmethods
Bacterial strains
All laboratory mutants were derived from the susceptible
wild-type strain PAO1, here called PT5 (Table 1). The nalB
mutant PT629 (Cosson et al., 2002) overexpresses OprM as
determined by western blot analysis (T. Ko¨hler et al.,
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unpublished result). PT629 has a 4 base pair (bp) deletion at
position 363 in the mexR gene, while strain PT648 (Ko¨hler
et al., 1997b) contains an AC deletion at codon 19 in nfxB,
resulting in the overproduction of MexCD–OprJ (nfxB
phenotype). The nfxC mutant PT149 (formerly PAO-7H)
(Ko¨hler et al., 1997a) overproduces MexEF–OprN because
of the synthesis of a full-lengthmexT gene that is interrupted
by an 8 bp DNA sequence in the susceptible wild-type strain
PT5 (Ko¨hler et al., 1999; Maseda et al., 2000). AmpC-
derepressed strains PT1155 and PT1156 were selected by
spreading c. 109 cells of PT5 on Luria–Bertani (LB) agar
supplemented with 30mg L1 cefotaxime and incubating at
37 1C for 48 h. Clinical strains used in this study are shown
in Table 1. The susceptible Pseudomonas aeruginosa clinical
isolate 302S (designated as strain 1 in Miche´a-Hamzehpour
et al., 1987), was obtained from a blood culture of a patient
hospitalized at the University Hospital Geneva. Resistant
derivatives of this strain were selected in a murine peritonitis
model using a single dose (25mg kg1) of pefloxacin or
ciprofloxacin (Miche´a-Hamzehpour et al., 1987). Minimal
inhibitory concentration (MIC) determinations and western
blot analyses using antibodies against OprJ- and OprN-
identified strains 302-R9J and 302-R11J as nfxB mutants,
while strains 302-R9N and 302-R11N were nfxC mutants
(data not shown). Three well-characterized pairs of isogenic
susceptible and b-lactam-resistant clinical isolates (14/12,
18/17 and 96/109) (Table 1) were used for analysis of mexA,
mexB and oprM expressions (Ziha-Zarifi et al., 1998).
Strains were grown with agitation (250 r.p.m.) at 37 1C in
LB medium.
IsolationoftotalRNA
Strains were inoculated from glycerol stocks into 2mL LB
medium and grown overnight (o/n) at 37 1C. Strains were
subcultured in 5mL LB medium and grown to mid-expo-
nential phase (OD600 = 1.5–2.0). A 0.25mL aliquot of this
culture, corresponding to 5 108 cells, was added to 0.5mL
of RNAeasy bacteria protect solution (Qiagen, Hilden,
Germany). Total RNAwas isolated according to the instruc-
tions of the supplier. Residual DNA was eliminated by
DNAse treatment using 20U of RQ1 RNAse-free DNAse
(Promega, Madison, WI). After removal of DNAse by
phenol/chloroform extraction, RNA was precipitated and
resuspended in 30 mL of RNAse-free H2O. The final yield
was c. 15 mg of RNA (260/280 ratio of 4 1.8).
Synthesis of cDNAforRT-PCR
A reaction mix containing 1 mg of RNAwas incubated in the
presence of 250 ng random hexamers (Promega) and dNTPs
(833 mM final concentration) in a total volume of 24 mL at
65 1C for 5min. After chilling the mix on ice, 8 mL 5 first-
strand buffer, 4 mL of 25mM MgCl2 and 2 mL RNAsin
RNAse inhibitor (Promega) were added. The reaction was
preincubated for 10min at 25 1C and then 2min at 42 1C.
The mix was divided into two 19 mL aliquots. To one aliquot,
1 mL (5U) of ImPromII reverse transcriptase (Promega) was
added; the other half served as a negative control to detect
the amount of residual genomic DNA in the RNA prepara-
tions. Both samples were incubated at 42 1C for 50min.
Reverse transcriptase was inactivated by incubation at 70 1C
Table 1. Bacterial strains
Strain Phenotype Genotype Reference
PT5 PAO1 wild type Lab collection
PT629 PT5nalB, overexpresses MexAB–OprM 4 bp deletion in mexR Ko¨hler et al. (1997b)
PT648 PT5nfxB, overexpresses MexCD–OprJ 2 bp deletion in nfxB Cosson et al. (2002)
PT149 PT5nfxC, overexpresses MexEF–OprN 8 bp deletion in mexT Ko¨hler et al. (1997a)
PT364 PT5oprD::OTc, lacks OprD Epp et al. (2001)
PT1102 PT5 imi-R, decreased OprD expression ND Perron et al. (2004)
PT1105 PT5 imi-R, decreased OprD expression CzcS Val194Leu Perron et al. (2004)
PT1108 PT5 imi-R, decreased OprD expression CzcS Val194Leu Perron et al. (2004)
PT1155 PT5 ctx-R, derepressed AmpC ND This study
PT1156 PT5 ctx-R, derepressed AmpC ND This study
302S Susceptible blood isolate Miche´a-Hamzehpour et al. (1987)
302R9J 302SnfxB, overexpresses MexCD–OprJ NfxB End200Cys Unpublished
302R11J 302SnfxB, overexpresses MexCD–OprJ 1 bp deletion in nfxB Unpublished
302R9N 302SnfxC, overexpresses MexEF–OprN ND Unpublished
302R11N 302SnfxC, overexpresses MexEF–OprN ND Unpublished
14 Susceptible clinical isolate Ziha-Zarifi et al. (1998)
12 14nalB, overexpresses MexAB–OprM MexR Asp8Glu Ziha-Zarifi et al. (1998)
18 Susceptible clinical isolate Ziha-Zarifi et al. (1998)
17 18nalB, overexpresses MexAB–OprM 1 bp deletion in mexR Ziha-Zarifi et al. (1998)
96 Susceptible clinical isolate Ziha-Zarifi et al. (1998)
109 96nalB, overexpresses MexAB–OprM 11 bp deletion in mexR Ziha-Zarifi et al. (1998)
imi-R, imipenem-resistant; ctx-R, cefotaxime-resistant; ND, not determined; bp, base pair.
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for 15min. The cDNAs obtained were stored at  20 1C
until use.
RT-PCRanalysis
The primers for the PCR amplification of cDNA were
designed using the primer3 program available at the website
(www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.
cgi) and are shown in Table 2. A Rotor Gene RT-PCR
machine (Corbett Research, Sydney, Australia; Model
RG3000, software version 6) was used for the quantification
of cDNA. Duplicate PCR reactions were performed using
the SYBR Green Quantitect Kit (Qiagen). Three microliters
of a 1 : 10 dilution of the cDNAwas used in a total volume of
15 mL. After a 15min activation of the modified Taq poly-
merase at 95 1C, 40 cycles of 20 s at 95 1C, 20 s at 60 1C and
30 s at 72 1C were performed. Data were acquired at 72 1C. A
melt curve was run at the end of the 40 cycles to test for the
presence of a unique PCR reaction product. To check for re-
sidual contaminating genomic DNA, control reactions with-
out reverse transcriptase were analyzed in the same way
using the rpsL-F/R primers. The amount of signal in the con-
trols was usually close to the nontemplate control (NTC).
To correct for differences in the amount of starting
material, the ribosomal rpsL gene was chosen as a house-
keeping reference gene. Results are presented as ratios of
gene expression between the target gene (target) and the
reference gene (rpsL), which were obtained according to the
following equation: Ratio ¼ ðEtarget geneÞDCttargetðPT5test strainÞ=
ðErpsLÞDCtrpsLðPT5test strainÞ (Pfaffl et al., 2002), where E is the
real-time PCR efficiency for a given gene and Ct the crossing
point of the amplification curve with the threshold.
An effect on gene expression was considered significant
when the corresponding ratios were 4 2.5 or o 0.4.
b-lactamaseactivityandOprDwestern blot
analysis
b-lactamase activity was determined in cell-free extracts of
LB-grown cultures using nitrocefin as a substrate. LB
Table 2. Primer sequences
Primer 50-sequence-3 0 Length (bp) Position in gene Product length (bp)
mexR1 CGCGAGCTGGAGGGAAGAAACC 22 217 150
mexR2 CGGGGCAAACAACTCGTCATGC 22 366
mexA1 CGACCAGGCCGTGAGCAAGCAGC 23 375 316
mexA2 GGAGACCTTCGCCGCGTTGTCGC 23 668
oprM1 GATCCCCGACTACCAGCGCCCCG 23 60 247
oprM2 ATGCGGTACTGCGCCCGGAAGGC 23 265
nfxB1 CGCCTGATCAAGGAACACCTCACC 24 244 164
nfxB2 CGAAACACGCCTTTCTGCTGTCC 23 407
mexC1 ATCCGGCACCGCTGAAGGCTGCG 23 284 344
mexC2 CGGATCGAGCTGCTGGATGCGCG 23 605
mexC3 GTACCGGCGTCATGCAGGGTTC 22 1101 164
mexC4 TTACTGTTGCGGCGCAGGTGACT 23 1164
oprJ1 GTTCCGGGCCTGAATGCCGCTGC 23 345 305
oprJ2 TCGCGGCTGACCAGGGTCTGACG 23 627
mexZ1 GCATGGGCTTTCTCCGCCAGTGC 23 266 364
mexZ2 GCGTCCGCCAGCAACAGGTAGGG 23 629
mexX1 TGAAGGCGGCCCTGGACATCAGC 23 302 326
mexX2 GATCTGCTCGACGCGGGTCAGCG 23 605
mexT1 CAGCACCGCGGTGTTCCGCATCG 23 420 216
mexT2 ACGGTCTTGCGCTTGGCGTTGGC 23 635
mexE4 CCAGGACCAGCACGAACTTCTTGC 24 944 114
mexE5 CGACAACGCCAAGGGCGAGTTCACC 25 831
oprN1 CAACCGGGAGTGACCGAGGACCG 23 358 235
oprN2 TGCTCAGGGCAATCTTCTCGCGC 23 570
ampC1 CGGCTCGGTGAGCAAGACCTTC 22 264 218
ampC2 AGTCGCGGATCTGTGCCTGGTC 22 481
oprD1 ATCTACCGCACAAACGATGAAGG 23 772 156
oprD2 GCCGAAGCCGATATAATCAAACG 23 927
oprD3 CTCGACGGCACCTCCGACAAGAC 23 287 232
oprD4 AGCCCTTCGAATTCGCTGCTCTG 23 518
rpsL-F GCAAGCGCATGGTCGACAAGA 21 35 201
rpsL-R CGCTGTGCTCTTGCAGGTTGTGA 23 235
bp, base pair.
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medium was inoculated 1 : 100 with o/n cultures. Where
indicated, b-lactamase synthesis was induced by adding
500mg L1 benzyl penicillin during exponential growth.
After 2 h of incubation, cells were harvested by centrifuga-
tion at 8 1C at 3200 g for 10min. The pellet was washed twice
and finally resuspended in cold 10mMNa-phosphate buffer
(pH 7.0). Cells were sonicated (5 20 pulses, power level 3
on a Branson sonicator) and centrifuged for 10min at
15 500 g at 8 1C. The b-lactamase activity was determined
by a kinetic assay in 10mM Na-phosphate buffer (pH 7.0)
using nitrocefin (0.1mM final concentration) as the sub-
strate. b-lactamase activity is expressed as the difference in
absorption at OD482 per minute per milligram protein cell-
free extract.
Western blots using a polyclonal OprD antibody were
performed on total cell lysates as described previously
(Perron et al., 2004).
Results anddiscussion
To assess the possibility of using qRT-PCR to detect anti-
microbial resistance mechanisms in Pseudomonas aerugino-
sa, we measured gene expression of the four major Mex
efflux pumps, the chromosomal AmpC b-lactamase and the
porin OprD in both laboratory and well-characterized
clinical strains (Table 1).
ExpressionanalysisofMexeffluxpumpgenes
While genome analysis of P. aeruginosa has revealed the pre-
sence of 11 RND-type efflux pumps (www.pseudomonas.
com), only the MexAB–OprM, MexCD–OprJ, MexEF
–OprN andMexXY pumps have been shown to be of clinical
relevance. For each of these four efflux pump operons, we
determined the expression of at least two pump genes and
the corresponding regulator gene in isogenic susceptible (S)
and antibiotic-resistant (R) P. aeruginosa strains.
We first analyzed gene expression of the constitutively
expressed mexAB–oprM operon in laboratory strains PT5
and PT629 and in three pairs of isogenic S/R clinical isolates
(14/12, 18/17, 96/109). The R strains were previously shown
by western blot analysis to overexpress the OprM outer
membrane protein (Ziha-Zarifi et al., 1998). Compared with
the laboratory strain PT5, the isogenic nalB mutant PT629
showed a four- to sixfold higher expression of mexA, mexB
and oprM (Table 3). These results are in agreement with a
fourfold increase in mexB expression as determined by qRT-
PCR in the nalB mutant OCR1 (Yoneda et al., 2005) and
with the a 4.2-fold increase in the activity of a mexA–phoA
reporter fusion in the nalB strain K1496 (Srikumar et al.,
2000). Expression of the mexR regulator was dowregulated
fivefold in the nalB mutant PT629, which is surprising
considering the reported negative autoregulation of MexR
(Poole et al., 1996b). In the three nalB clinical isolates, 12, 17
and 109, expression of mexA, mexB and oprM was four- to
10-fold higher than in PT5 (Table 4) and was comparable
with the nalB laboratory strain PT629 (Table 3). A notable
exception was the 35-fold higher mexR expression in the
nalB strain 109, which is in agreement with the loss of
negative autoregulation of mexR (Poole et al., 1996b).
In contrast to the constitutively expressed MexAB–OprM
pump, the MexCD–OprJ efflux system (Poole et al., 1996a)
can be induced by cationic ions like tetraphenylphospho-
nium chloride and ethidium bromide (Morita et al., 2001),
but is expressed at clinically relevant levels only when
Table 3. Relative expression levels of antibiotic resistance genes in laboratory strains as determined by qRT-PCR
Gene
Strains
PT5 wt PT629 nalB PT648 nfxB PT149 nfxC PT51Tet
mexR 1.0 0.2 1.7 0.2 0.3
mexA 1.0 6.1 1.7 0.5 0.6
mexB 1.0 5.0 1.1 0.2 0.4
oprM 1.0 4.2 1.2 0.4 1.0
nfxB 1.0 0.9 14.7 0.7 1.6
mexC 1.0 1.3 74.5 2.9 4.0
oprJ 1.0 3.2 33.4 2.9 3.8
mexZ 1.0 0.2 2.3 0.4 3.8
mexX 1.0 1.9 1.6 0.4 8.5
mexY 1.0 0.9 1.8 0.2 10.9
mexT 1.0 1.2 2.1 1.9 1.7
mexE 1.0 2.4 4.4 796.0 3.5
oprN 1.0 1.5 2.6 162.0 2.9
Values represent fold change (mean of duplicate samples) in comparison with the transcription level in wild-type strain PT5.
In all cases the standard deviation for duplicate samples was less than 15% of the mean.
Values  0.4 are shown in italics, values Z2.5 are shown in bold.
qRT-PCR, quantitative real-time-PCR chain reaction.
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mutations arise in the cognate repressor gene nfxB (Hirai
et al., 1987; Okazaki & Hirai, 1992; Morita et al., 2001).
As expected, the nfxB mutant PT648 derived from the
laboratory strain PT5 showed a marked increase in both
mexC (75-fold) and oprJ (33-fold) expressions (Table 3),
which was accompanied by a 15-fold increase in the
transcription of the repressor gene nfxB (Table 3). This can
be explained by the loss of negative autoregulation of nfxB as
observed by Shiba et al. (1995). We then tested two nfxB
mutants derived from the clinical isolate 302S by exposure
to pefloxacin in a mouse peritonitis model (Miche´a-Ham-
zehpour et al., 1987). These strains showed MIC profiles
reminiscent of nfxB mutants and overexpressed the OprJ
outer membrane protein (data not shown). MexC and oprJ
genes were overexpressed c. 300- and 170-fold, respectively
Table 4). As in the laboratory mutant, nfxB expression in the
clinical strains was derepressed (35- to 40-fold compared
with PT5). Expression of the genes from the mexAB–oprM,
mexEF–oprN and mexXY pumps were not significantly
affected in these nfxB mutants (Table 4).
The mexEF–oprN operon (Ko¨hler et al., 1997a) is posi-
tively regulated by the LysR-type activator protein MexTand
is overexpressed in nfxC mutants (Ko¨hler et al., 1999). In
PT5, as well as in the PAO1 strain used for the genome
sequencing project (Stover et al., 2000), the mexT structural
gene is prematurely terminated by the presence of an 8 bp
DNA sequence (Maseda et al., 2000) located near the 50 end
of mexT (Cosson et al., 2002). The nfxC mutant PT149
produces a full-length mexT resulting in the expression of
mexEF–oprN (Maseda et al., 2000). As expected, expressions
of mexE (796-fold) and oprN (162-fold) had increased
drastically in PT149, while expression of mexT itself was
not affected significantly (Table 3). In the two nfxCmutants,
302 R9N and 302 R11N, selected in the mouse after
pefloxacin treatment (Miche´a-Hamzehpour et al., 1987),
gene inductions for mexE and oprN were at least 250- and
100-fold, respectively (Table 4), which are in agreement with
the values observed in the laboratory strains. Again expres-
sion ofmexTwas not altered in the nfxCmutants, suggesting
that mexEF–oprN expression occurs via activation of mexT
at the genetic level (removal of 8 bp sequence), although
activation at the protein level or through additional regula-
tory circuits cannot be excluded.
The mexXYoperon does not contain a gene coding for an
outer membrane protein but is able to recruit OprM of the
MexAB–OprM efflux pump to form a functional tripartite
efflux system (Mine et al., 1999; Ramos-Aires et al., 1999).
MexXY–OprM is involved in the intrinsic and acquired
resistance of P. aeruginosa to aminoglycoside antibiotics
(Ramos-Aires et al., 1999). We induced the expression of
this efflux pump gene by incubating the laboratory strain
PT5 in the presence of 2mg L1 tetracycline as described
previously (Masuda et al., 2000). Under these conditions,
mexX and mexY expressions increased nine- and 11-fold,
respectively (Table 3). The three- to fourfold inductions of
mexC–oprJ and mexE–oprN genes by tetracycline are not
expected to result in any effect on MICs given the more than
30-fold expression ratios for these pump genes in nfxB and
Table 4. Relative expression levels of antibiotic resistance genes in clinical isolates as determined by qRT-PCR
Gene
Strains
PT 5 wt 14 12 nalB 18 17 nalB 96 109 nalB 302S 302 R9J nfxB 302 R11J nfxB 302 R9N nfxC 302 R11N nfxC
mexR 1.0 0.7 0.5 0.7 1.4 0.4 35.0 0.6 1.3 0.3 0.3 0.8
mexA 1.0 1.3 7.0 1.5 4.6 0.9 4.3 1.6 1.3 1.4 1.3 1.5
mexB 1.0 2.4 10.2 1.9 9.8 1.5 10.6 0.8 0.9 0.8 0.1 0.7
oprM 1.0 1.7 4.8 1.2 7.2 1.1 5.2 0.4 0.3 0.3 0.2 0.2
nfxB 1.0 1.1 0.5 1.0 0.5 0.4 0.4 1.3 41.2 34.8 1.3 1.5
mexC 1.0 0.7 0.6 0.8 0.2 0.6 0.6 0.7 272.3 339.4 0.4 1.2
oprJ 1.0 0.7 0.7 0.9 0.3 0.4 0.4 0.5 179.6 160.5 0.3 0.6
mexT 1.0 2.9 1.5 3.3 1.6 1.0 1.6 3.1 7.4 2.4 2.0 3.2
mexE 1.0 5.6 6.4 3.3 1.4 1.7 1.6 1.2 5.5 1.3 249.9 568.0
oprN 1.0 2.4 4.7 1.9 0.7 0.9 0.8 1.0 2.9 1.1 107.2 193.4
mexZ 1.0 0.1 0.1 0.05 0.02 0.05 0.06 0.5 2.1 0.5 0.4 0.8
mexX 1.0 8.7 11.0 1.0 0.4 6.9 7.5 0.7 1.5 0.5 0.2 0.6
mexY 1.0 8.2 6.5 0.9 0.1 5.2 5.2 0.6 1.3 0.4 0.4 0.6
ampC 1.0 1.7 1.5 2.5 1.2 1.1 1.5 1.4 7.5 0.9 0.7 1.1
oprD 1.0 2.7 0.7 o 0.01 o 0.01 1.2 1.6 0.07 0.07 0.02 0.04 0.01
mexC3/4 primers were used for strains derived from 302S and mexC1/2 primers for strains 14, 12, 18, 17, 96, 109.
Values represent fold change (mean of duplicate samples) in comparison with the transcription level in wild-type strain PT5.
In all cases the standard deviation for duplicate samples was less than 15% of the mean.
Values  0.4 are shown in italics, values Z2.5 are shown in bold.
qRT-PCR, quantitative real-time PCR.
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nfxC mutants, respectively. These results are comparable
with those obtained with aminoglycoside-resistant clinical
isolates, which showed a six- to 15-fold increase in mexY
(amrB) expression in comparison with PAO1, as estimated
by semiquantitative RT-PCR (Westbrock-Wadman et al.,
1999), and with a fivefold increase in mexY expression in a
mexZ mutant (Yoneda et al., 2005). However, upregulation
of mexX by 30- to 312-fold compared with PAO1 was
recently reported in aminoglycoside-resistant clinical iso-
lates (Llanes et al., 2004). A decrease in the expression of
both mexX and mexY genes in the nfxC mutants PT149 and
302 R9 could explain hypersusceptibility of this type of
mutants to gentamicin and kanamycin (Fukuda et al., 1990).
Interestingly, both the b-lactam susceptible and resistant
clinical isolates 14/12 and 96/109 showed a five- to 11-fold
higher expression of mexX and mexY than the laboratory
strain PT5 (Table 4). This would explain the previously
reported elevated MICs (4–16mg L1) of cefepime (Ziha-
Zarifi et al., 1998), a b-lactam transported not only by
MexAB–OprM but also by the MexXY efflux pump (Ra-
mos-Aires et al., 1999). Low mexZ expression compared
with PT5 was observed in the clinical isolates 14/12, 18/17
and 96/109 (Table 4). Reduced levels of the mexZ repressor
gene could explain the increased expression of mexXY in
strains 14/12 and 96/109, but surprisingly did not have any
effect in strains 18/17. Hence, control of the mexXY operon
in these strains might involve further regulatory elements, as
previously suggested (Llanes et al., 2004).
In summary, our data show qualitatively comparable
results between gene and protein expression for oprM, oprJ
and oprN. Together with the recently established quantita-
tive correlation for mexB and mexY gene and protein
expression (Yoneda et al., 2005) our results support the use
of qRT-PCR for the expression analysis of the four major
efflux pumps in P. aeruginosa.
AnalysisofAmpCexpression
The chromosomal AmpC b-lactamase confers resistance to
penicillins and most cephalosporins in P. aeruginosa. Its
expression is inducible and can be partially or completely
derepressed because of mutational events in regulatory loci
(Langaee et al., 2000). To extend our gene expression
analysis, we evaluated whether expression of the ampC gene
reflects b-lactamase activity. We selected on cefotaxime-
containing plates two PT5 derivatives, called PT1155 and
PT1156, which showed increased MICs to cefotaxime and
ceftazidime. AmpC expression determined by qRT-PCR in
these strains correlated with b-lactamase activity and MIC
levels of cefotaxime. Expression of ampC could also be
induced in the wild-type strain by the addition of benzylpe-
nicillin (500mg L1) (Table 5). As expected, ampC levels
measured in the three clinical S/R pairs were comparable
with those of PT5, confirming the absence of b-lactamase
activity (Ziha-Zarifi et al., 1998). Furthermore, we recently
found a good correlation between ampC expression deter-
mined by qRT-PCR and the MIC profiles in more than 30
clinical isolates (A. Reinhardt et al., unpublished data).
AnalysisofOprDexpression
Carbapenems, in particular imipenem and meropenem,
enter P. aeruginosa cells via facilitated diffusion through the
OprD porin (Trias et al., 1989). Mutants resistant to these
molecules are characterized by decreased amounts or com-
plete loss of OprD (Trias et al., 1989). We measured oprD
gene expression levels by qRT-PCR and compared themwith
OprD protein levels as determined by western blot in whole-
cell extracts from four carbapenem-resistant derivatives of
the laboratory strain PT5 (Fig. 1). As expected, OprD
protein was less abundant or undetectable in all imipenem-
resistant strains. Furthermore, oprD gene expression levels
paralleled the amount of OprD protein determined in total
cell extracts (Fig. 1). In the clinical isolates 14/12 and 96/109
oprD levels were comparable with PT5, while those of the
pair 18/17 decreased more than 100-fold. In agreement with
these data, imipenem MICs were 1/0.5mg L1 for the first
two pairs of strains while those of the latter pair were
4/4mg L1 (Ziha-Zarifi et al., 1998).
Surprisingly, in the clinical isolate 302S and its derivatives
we were initially unable to detect any oprD expression above
the NTC background. We therefore repeated the qRT-PCR
with another primer pair (oprD3/4), which yielded low but
detectable amounts of oprD (Table 4). When the ratios were
calculated with respect to strain 302S (ratio = 1), those of the
two nfxB mutants were comparable (0.97 and 0.59) while
Table 5. Minimal inhibitory concentrations and b-lactamase expression for wild-type and cefotaxime-selected strains
Strains CIP CTX CFA AZT b-lactamase activity qRT-PCR fold increase for ampC
PT5 0.06 8 1 4 1.2 0.2 1
PT51BP ND ND ND ND 16.2 2.3 7.4
PT1155 0.06 128 4 4 13.3 5.3 4.9
PT1156 0.06 256 16 8 290.1 0.7 34.7
BP, benzylpenicillin (500 mg L1) was added for induction of ampC in PT5.
CIP, ciprofloxacin; CTX, cefotaxime; CFA, ceftazidime; AZT, aztreonam; ND, not determined; qRT-PCR, quantitative real-time PCR.
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those of the nfxC mutants were four- to fivefold lower (0.28
and 0.19). These results are in agreement with the elevated
imipenem MICs (4–8mg L1) for the nfxC mutants com-
pared with those of the susceptible strain 302S and its nfxB
derivatives (0.5–1mg L1).
OprD has been shown to be regulated both at the
transcriptional (Ochs et al., 1999) and the posttranscrip-
tional level (Ko¨hler et al., 1999). A study comparing oprD
gene and protein expression in 25 imipenem-resistant or
susceptible clinical isolates showed decreased oprD gene
expression in 17 out of 18 resistant isolates and ‘normal’
gene expression in six out of the seven susceptible isolates
(Pirnay et al., 2002), providing further support for a
correlation between oprD gene expression and imipenem
resistance.
General conclusions
In this study, we performed in 16 Pseudomonas aeruginosa
isolates from both laboratory and clinical origin an expres-
sion analysis on 15 genes involved in antibiotic resistance.
These included the four major mex efflux pump genes as
well as ampC and oprD. Importantly, we observed that
expression levels of these genes were comparable between
the laboratory strain PT5 and the four susceptible clinical
isolates (302S, 14, 18 and 96) with the notable exception of
oprD in strain 302S. In both laboratory and clinical nalB
mutants, we observed modest four- to 11-fold increases in
the expression of the mexAB–oprM and mexXY pumps. In
contrast, genes of the normally silent mexCD–oprJ and
mexEF–oprN operons showed much higher expression ra-
tios (30- to 796-fold) in nfxB and nfxCmutants, respectively.
Since mexAB–oprM is already expressed constitutively in
susceptible wild-type strains, a modest increase in gene
transcription is apparently sufficient to further increase the
resistance level. On the other hand, mexCD–oprJ and
mexEF–oprN are not or weakly transcribed in susceptible
strains and higher expression ratios of 70-fold for mexC and
250-fold for mexE seem to be required to observe an effect
on the antibiotic susceptibility level.
Moreover, we found qualitative correlations between
ampC expression determined by qRT-PCR and b-lactamase
activity as well as for oprD expression and the amount of
OprD protein estimated by western blot analysis in labora-
tory strains.
We are aware that identification of resistance mechanisms
based on gene expression analysis might be complicated
when several mechanisms affecting the same class of anti-
biotics are at work. Other caveats for this method are
inherent to gene expression analysis in general, namely the
fact that the presence of a transcript does not necessarily
mean that it encodes a functional protein. Furthermore,
posttranscriptional regulatory events influence protein ex-
pression and hence the phenotype. Certain genes may
present hypervariable regions or mosaic structures like for
instance oprD, which can acquire additional mutations and
deletions in imipenem-resistant strains (Pirnay et al., 2002;
El Amin et al., 2005). In this case it might be difficult to
design a single universal primer pair for a given gene and
negative results in the qRT-PCR should be confirmed with
another primer pair, as shown in our study. However, this
problem also arises during immunological protein detection
as mosaic structures and polymorphisms might affect the
protein structure preventing recognition by monoclonal
antibodies.
In summary, our data strongly support the use of qRT-
PCR as a rapid and sensitive method to determine the
expression profile of antibiotic resistance determinants in P.
aeruginosa. In the hospital setting, this method should allow
a more targeted choice of antimicrobial treatments in
particular once efflux pump inhibitors will be available.
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